Cite
HARVARD Citation
Colombel, J. et al. (n.d.). S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease: Results From a Randomized Phase 3 U-EXCEL Study. American journal of gastroenterology. p. e518. [Online].